Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Marshall Edwards and NIDCR to study phenoxodiol

July 29, 2002

Merck describes basic research in the area of tyrosine kinase inhibitors

July 26, 2002

Aromatase inhibitor from Yamanouchi withdrawn from development

July 26, 2002

Eligard 22.5 mg approved for advanced prostate cancer

July 25, 2002

New FTase inhibitors in early development at Schering-Plough

July 25, 2002

VE-cadherin antibody for cancer and other disorders associated with angiogenesis

July 25, 2002

New CDK inhibitors identified at BMS

July 24, 2002

AstraZeneca patent describes MEK inhibitors for use in cancer

July 23, 2002

Phase II Aroplatin trial enrolling in metastatic colorectal cancer

July 22, 2002

Selective PARP1/PARP2 inhibitors described by Iconix R&D team

July 22, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...